[1] GAO X, CUI S. Crystal structure of the SARS-CoV-2 PLpro with GRL0617[C]. 2020: 0. DOI:10.2210/PDB7CMD/PDB.
[2] LUKAS KERTI Vladimir F. Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure–activity relationships[J]. Bioorganic & Medicinal Chemistry, 2024, 113: Article 117909. DOI:
10.1016/j.bmc.2024.117909.
[3] PRIYASHI RAO. Identifying structural–functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation[J]. Molecular Diversity, 2021, 26 1: 309-329. DOI:10.1007/s11030-021-10220-8.
[4] KIIRA RATIA. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2008: 16119-16124. DOI:
10.1073/pnas.0805240105.